08:00 Thu 02 May 2019
Shield Therapeutics - Investor presentation
(the "Company")
Investor presentation
ShareSoc is an organisation dedicated to supporting individual private shareholders ensuring that they have a voice and better access to information on the companies they invest in.
The event will commence at
No new material information will be disclosed during the event.
If you are interested in attending the event and would like information on how to register please contact Walbrook PR at shield@walbrookpr.com
For further information please contact:
|
|
|
+44 (0)20 7186 8500 |
|
|
|
|
Financial PR & IR Advisor |
|
Walbrook PR |
+44 (0)20 7933 8780 or shield@walbrookpr.com |
|
+44 (0)7980 541 893 / +44 (0)7841 917 679 |
About
Shield is a de-risked, commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. The Company's clear purpose is to help its patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Feraccru®, for the treatment of iron deficiency in adults which has exclusive IP rights until the mid-2030s. Feraccru® is commercialised in the
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE